CR11745A -
USE OF DRONEDARONA TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT OF PATIENTS WITH ARRITMIA AND THAT HAVE AN INCREASE OF THE CREATIN LEVEL DUE TO THE ADMINISTRATION OF DRONEDARONA
- Google Patents
USE OF DRONEDARONA TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT OF PATIENTS WITH ARRITMIA AND THAT HAVE AN INCREASE OF THE CREATIN LEVEL DUE TO THE ADMINISTRATION OF DRONEDARONA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi AventisfiledCriticalSanofi Aventis
Publication of CR11745ApublicationCriticalpatent/CR11745A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Utilización de dronedarona o una de sus sales aceptables farmacéuticamente para preparar un medicamento para el tratamiento de pacientes con arritmia, teniendo dichos pacientes un incremento en el nivel de creatinina debido a la administración de dronedarona, incrementándose dicho nivel de creatinina después del inicio del tratamiento con dronedarona, alcanzando dicho incremento del nivel de creatinina un plató y utilizándose como una línea base nueva, siendo dicho incremento dle nivel de creatinina reversible después de la suspensión de la dronedarona.Use of dronedarone or one of its pharmaceutically acceptable salts to prepare a medicament for the treatment of patients with arrhythmia, said patients having an increase in creatinine level due to the administration of dronedarone, said creatinine level increasing after the start of treatment with dronedarone, said increase in creatinine level reaching a set and being used as a new baseline, said increase in reversible creatinine level after dronedarone suspension.
CR11745A2008-04-282010-10-21
USE OF DRONEDARONA TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT OF PATIENTS WITH ARRITMIA AND THAT HAVE AN INCREASE OF THE CREATIN LEVEL DUE TO THE ADMINISTRATION OF DRONEDARONA
CR11745A
(en)
USE OF DRONEDARONA TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT OF PATIENTS WITH ARRITMIA AND THAT HAVE AN INCREASE OF THE CREATIN LEVEL DUE TO THE ADMINISTRATION OF DRONEDARONA
Use of an amount of laquinimod, which is used to prepare a medication to treat a human patient affected with multiple sclerosis or who has a clinically isolated syndrome; a package, an amount of laquinimod and a pharmaceutical composition thereof.
USE OF LAQUINIMOD FOR THE TREATMENT OF PATIENTS WITH CROHN'S DISEASE IN THOSE WHO FAILS AN ANTI-FACTOR THUMOR NECROSIS THERAPY a (ANTI-TNFa) FIRST LINE
Use of dabigatran etexilate or a salt thereof to prepare a useful medication for the prevention of stroke in patients suffering from atrial fibrillation.
USE OF DRONEDARONE TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT OF PATIENTS WITH ARRHYTHMIA AND WHO HAVE AN INCREASED CREATININE LEVEL DUE TO THE ADMINISTRATION OF DRONEDARONE.
Use of dabigatran etexilate or a salt thereof to prepare a useful medication for the prevention of stroke in patients suffering from atrial fibrillation.
USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THIS, FOR THE PREPARATION OF A MEDICINAL PRODUCT TO REGULATE THE LEVEL OF POTASSIUM IN THE BLOOD
USE OF DRONEDARONA TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT OF PATIENTS WITH ARRITMIA AND THAT HAVE AN INCREASE OF THE CREATIN LEVEL DUE TO THE ADMINISTRATION OF DRONEDARONA
USE OF CELIVARONA TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT OF PATIENTS WITH ARRITMIA AND THAT HAVE AN INCREASE OF THE CREATININE LEVEL DUE TO THE ADMINISTRATION OF CELIVARONA